Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
11 |
Material Type: Article
|
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis BOgawa, Eiichi ; Nomura, Hideyuki ; Nakamuta, Makoto ; Furusyo, Norihiro ; Koyanagi, Toshimasa ; Dohmen, Kazufumi ; Ooho, Aritsune ; Satoh, Takeaki ; Kawano, Akira ; Kajiwara, Eiji ; Takahashi, Kazuhiro ; Azuma, Koichi ; Kato, Masaki ; Shimoda, Shinji ; Hayashi, JunLiver international, 2020-07, Vol.40 (7), p.1578-1589 [Peer Reviewed Journal]United States: Wiley Subscription Services, IncFull text available |
|
12 |
Material Type: Article
|
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis BNam, Heechul ; Han, Ji Won ; Lee, Soon Kyu ; Yang, Hyun ; Lee, Hae Lim ; Sung, Pil Soo ; Song, Myeong Jun ; Kwon, Jung Hyun ; Jang, Jeong Won ; Chang, U‐Im ; Kim, Chang Wook ; Nam, Soon Woo ; Bae, Si Hyun ; Choi, Jong Young ; Yoon, Seung Kew ; Yang, Jin Mo ; Kim, Hee YeonJournal of gastroenterology and hepatology, 2024-08, Vol.39 (8), p.1673-1683 [Peer Reviewed Journal]Australia: Wiley Subscription Services, IncFull text available |
|
13 |
Material Type: Article
|
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational studyBaldin, G ; Ciccullo, A ; Capetti, A ; Rusconi, S ; Sterrantino, G ; Cossu, MV ; Giacomelli, A ; Lagi, F ; Latini, A ; Bagella, P ; De Luca, A ; Di Giambenedetto, S ; Madeddu, GHIV medicine, 2019-02, Vol.20 (2), p.164-168 [Peer Reviewed Journal]England: Wiley Subscription Services, IncFull text available |
|
14 |
Material Type: Article
|
Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabineCid‐Silva, Purificación ; Fernández‐Bargiela, Noelia ; Margusino‐Framiñán, Luis ; Balboa‐Barreiro, Vanesa ; Mena‐De‐Cea, Álvaro ; López‐Calvo, Soledad ; Vázquez‐Rodríguez, Pilar ; Martín‐Herranz, Isabel ; Míguez‐Rey, Enrique ; Poveda, Eva ; Castro‐Iglesias, ÁngelesBasic & clinical pharmacology & toxicology, 2019-04, Vol.124 (4), p.479-490 [Peer Reviewed Journal]England: Wiley Subscription Services, IncFull text available |
|
15 |
Material Type: Article
|
Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis BCheng, Pin‐Nan ; Feng, I‐Cher ; Chen, Jyh‐Jou ; Kuo, Hsing‐Tao ; Lee, Pei‐Lun ; Yu, Ming‐Lung ; Chiu, Yen‐Cheng ; Chiu, Hung‐Chih ; Chien, Shih‐Chieh ; Chen, Pei‐Jer ; Liu, Chun‐JenAlimentary pharmacology & therapeutics, 2024-01, Vol.59 (2), p.230-238 [Peer Reviewed Journal]England: Wiley Subscription Services, IncFull text available |
|
16 |
Material Type: Article
|
Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarateKaneko, Shun ; Kurosaki, Masayuki ; Tamaki, Nobuharu ; Itakura, Jun ; Hayashi, Tsuguru ; Kirino, Sakura ; Osawa, Leona ; Watakabe, Keiya ; Okada, Mao ; Wang, Wan ; Shimizu, Takao ; Higuchi, Mayu ; Takaura, Kenta ; Yasui, Yutaka ; Tsuchiya, Kaoru ; Nakanishi, Hiroyuki ; Takahashi, Yuka ; Watanabe, Mamoru ; Izumi, NamikiJournal of gastroenterology and hepatology, 2019-11, Vol.34 (11), p.2004-2010 [Peer Reviewed Journal]Australia: Wiley Subscription Services, IncFull text available |
|
17 |
Material Type: Article
|
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment‐naïve chronic hepatitis BLim, Jihye ; Choi, Won‐Mook ; Shim, Ju Hyun ; Lee, Danbi ; Kim, Kang Mo ; Lim, Young‐Suk ; Lee, Han Chu ; Choi, JonggiLiver international, 2022-07, Vol.42 (7), p.1517-1527 [Peer Reviewed Journal]United States: Wiley Subscription Services, IncFull text available |
|
18 |
Material Type: Article
|
Dyslipidaemia after switch to tenofovir alafenamide (TAF)‐based cART regimens in a cohort of HIV‐positive patients: what clinical relevance?Gazzola, L ; Tagliaferri, G ; De Bona, A ; Mondatore, D ; Borsino, C ; Bini, T ; Marchetti, G ; d’Arminio Monforte, AHIV medicine, 2021-02, Vol.22 (2), p.140-145 [Peer Reviewed Journal]England: Wiley Subscription Services, IncFull text available |
|
19 |
Material Type: Article
|
Tenofovir alafenamide is associated with improved alanine aminotransferase and renal safety compared to tenofovir disoproxil fumarateLiang, Lilian Yan ; Yip, Terry Cheuk‐Fung ; Lai, Jimmy Che‐To ; Lam, Amy Shuk‐Man ; Tse, Yee‐Kit ; Hui, Vicki Wing‐Ki ; Chan, Henry Lik‐Yuen ; Wong, Vincent Wai‐Sun ; Wong, Grace Lai‐HungJournal of medical virology, 2022-09, Vol.94 (9), p.4440-4448 [Peer Reviewed Journal]United States: Wiley Subscription Services, IncFull text available |
|
20 |
Material Type: Article
|
Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus InfectionMurata, Kazumoto ; Tsukuda, Senko ; Suizu, Futoshi ; Kimura, Akihiro ; Sugiyama, Masaya ; Watashi, Koichi ; Noguchi, Masayuki ; Mizokami, MasashiHepatology (Baltimore, Md.), 2020-05, Vol.71 (5), p.1533-1545 [Peer Reviewed Journal]United States: Wiley Subscription Services, IncFull text available |